六连板人民同泰称公司当前股价涨幅与经营业绩、行业情况严重偏离

Group 1 - The stock price of Renmin Tongtai (600829) experienced a cumulative increase of 20% over two consecutive trading days, leading to a classification of abnormal trading fluctuations according to the Shanghai Stock Exchange regulations [1] - From November 10 to 17, Renmin Tongtai's stock hit the daily limit for six consecutive trading days, with a total increase of 77.21% during this period [1] - The trading volume over the last three days showed significant fluctuations, with turnover rates of 1.2%, 7.37%, and 13.24%, indicating potential risks of speculative trading [1] Group 2 - The company reported that its current stock price increase is severely disconnected from its operational performance and industry conditions, urging investors to be cautious of performance volatility and high valuation risks [2] - As of November 14, the company's rolling price-to-earnings (P/E) ratio was 73.64, significantly higher than the industry average P/E ratio of 18.91 for the pharmaceutical commercial sector [1]